VSE Capital Markets

Divis Laboratories Ltd

NSE : DIVISLABBSE : 532488ISIN CODE : INE361B01024Industry : Pharmaceuticals - Indian - Bulk Drugs

BSE3,134.70 -21.60 (-0.68%)

PREV CLOSE (₹) 3,156.30

OPEN PRICE (₹) 3,179.00

BUY PRICENA(×)

SELL PRICE NA(×)

VOLUME 27,107

TODAY'S RANGE (₹)3,210.003,110.30

52 WK RANGE(₹)3,388.001,627.15

NSE3,131.45 -25.40 (-0.80%)

PREV CLOSE( ₹ ) 3,156.85

OPEN PRICE (₹) 3,159.75

BUY PRICE 3,131.45(×481)

SELL PRICEN/A

VOLUME 1,412,166

TODAY'S RANGE(₹) 3,210.903,110.00

52 WK RANGE (₹)3,389.001,626.00

Stock Summary

MARKET CAP (₹ CR)	83,216.44
P/E	52.09
BOOK VALUE (₹)	275.61
DIV (%)	800.00
MARKET LOT	1.00

EPS (TTM)	60.18
PRICE/BOOK	11.37
DIV YIELD.(%)	0.51
FACE VALUE (₹)	2.00
DELIVERABLES (%)	19.75

Background Information

Incorporation Year	1990
Registered Office	1-72-23(P)/DIVIS/303 Divi Towe,Cyber Hills Gachibowli Hyderabad,Telangana-500032
Telephone	91-40-23786300/23786352/400,Managing Director
Fax	91-40-23786460
Chairman	Ramesh B V Nimmagadda
Managing Director	Murali K Divi
Company Secretary	Satish Choudhury
Auditor	Price Waterhouse Chartered Accountants LLP
Face Value	2
Market Lot	1
Listing	BSE,MSEI ,NSE,
Registrar	KFin Techologies Pvt Ltd Karvy Selenium Tow-B,31&32 Financial Dist,Nanakramguda ,Hyderabad-500032

MF Holdings

Scheme Name	Hold(%)
SBI Equity Hybrid Fund	4.00
SBI Bluechip Fund	4.88
AXIS Long Term Equity Fund	4.41
SBI ETF Nifty 50	0.80
AXIS Focused 25 Fund	4.78

News & Announcements

Date	News
27-Oct-2020	Divis Laboratories schedules board meeting
27-Oct-2020	Divis Laboratories Ltd - Board Meeting Intimation for Inter-Alia, Considering And Approving The Unaudited Financial Results For The Quarter And Half Year Ended 30 September, 2020
23-Oct-2020	Divis Laboratories Ltd - Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
23-Oct-2020	Divis Laboratories Ltd - Divis Laboratories Limited - Updates

Share Holding

Peer Group

Lupin Ltd 940.40 ( -1.67)	M.Cap (₹ in Cr) 42626.13
Jubilant Life Sciences Ltd 752.20 ( 0.29)	M.Cap (₹ in Cr) 11982.55
Granules India Ltd 378.20 ( -1.63)	M.Cap (₹ in Cr) 9365.77
Aarti Drugs Ltd 642.10 ( -4.99)	M.Cap (₹ in Cr) 5984.37
Sequent Scientific Ltd 148.10 ( -0.07)	M.Cap (₹ in Cr) 3678.37

3rd Floor,Fortune Tower,Sayajigunj, Vadodara 390020, Gujarat, India

Telephone: +91 265 2361534

Customer Care Number: +91 265 2361474

Customer Care Timings: Monday to Friday 8:30am to 6:15pm

Email Address: vse@vselindia.com / compliance@vselindia.com

Attention Investors:

"Prevent Unauthorized transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day .......... Issued in the interest of investors
No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorize your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
KYC is one time exercise while dealing in securities market - once KYC is done through a SEBI registered intermediary (broker , DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
Procedure to file a complaint on SEBI SCORES: Register on SCORES portal. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances.

For any complaints pertaining to securities broking please write to compliance@vselindia.com, for DP related to dp@vselindia.com. Please ensure you carefully read the Risk Disclosure Document as prescribed by SEBI.

Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed.